• Home
  • News
  • Rapid Vaccine Distribution to Over 7.5 Billion Humans
Back to the news list
03 November 2020

Rapid Vaccine Distribution to Over 7.5 Billion Humans

When a COVID-19 vaccine is developed and ready for distribution it will, in all likelihood, require cold chain services.

But, what environmental and economic costs will be attached to this logistical endeavour?

Who would have said a year ago that disruptions to supply chains, and more broadly, our way of life, would not come from a new company, a start-up, or a new economic model, but rather from a virus? The disruption caused by COVID-19 has been extensive, we cannot control its spread, and we do not understand its behaviour. How it affects our health varies from person to person for unknown reasons, and may include mild symptoms, severe symptoms, or even asymptotic cases in individuals who spread the virus unknowingly.

Let’s read the entire article.

This article is taken from Pharmaceutical Manufacturing and Packing Sourcer November 2020, pages 10-11. © Samedan Ltd

Other news

21 October 2024

 Proud to be featured in the latest edition of World Pharmaceutical Frontiers magazine!

In an Q&A,  Bob McClain, Americas Regional Sales Director, reveals how EMBALL'ISO is revolutionizing pharmaceutical transport through our innovative lightweight, reusable isothermal packaging solutions.
Read more
28 August 2024

EMBALL'ISO participates in Logipharma US 2024

We look forward to seeing you at Logipharma US 2024! Let's network and discuss how we can help your cold chain logistics.
Read more
18 June 2024

Meet us at INTERPHEX JAPAN 2024

MBALL`ISO Japan will participate to INTERPHEX Japan 2024 (26th -28th June 2024) at Tokyo Big Site. Our booth will be located at #40-33 in East-5 Hall.
Read more
14 May 2024

EMBALL'ISO is now established in Australia and New Zealand with a subsidiary

EMBALL’ISO is ready to start its full operation in Australia and New Zealand following the establishment of its subsidiary EMBALL'ISO Australia in 2023.
Read more